malaria vaccine

One of these products, the RTS, S candidate malaria vaccine, is now undergoing a very large phase III trial in Africa.

Scientists have recently confirmed that it is possible to develop a malaria vaccine.

The Roadmap marks the first concerted global attempt at mapping out a shared plan of action for making a preventive malaria vaccine reality.

And a malaria vaccine would be a good thing indeed.

A malaria vaccine has performed well in a small clinical trial of adults in Mali, leading to testing being expanded to children.

Drug resistance is a major threat, a future malaria vaccine is a potential opportunity.

The major Merozoite Surface Protein 1(MSP1) of Plasmodium falciparum is an important candidate for malaria vaccine.

It remains an urgent need to develop effective malaria vaccine for global control of malaria.

We have never had a malaria vaccine get that far.

"I am thrilled, " says Joe Cohen, who leads the malaria vaccine project at GSK Biologicals.

The study will aid malaria drug development and improves the chance of developing a malaria vaccine, Winzeler added.

Health Report - The Long Search for a Malaria Vaccine

A malaria vaccine which showed 58% protection against severe disease in a Phase II clinical trial in Mozambique;

Research Advance in Malaria Vaccine